Abstract:
Fibrolamellar Hepatocellular Carcinoma (FLC) is a rare liver cancer that primarily affects adolescents and young adults. Up to now there is only one identified molecular target responsible for driving the disease, the chimeric protein encoded by DNAJB1-PRKACA (J-PKAca). Immune cells have been identified as key players in liver cancer biology, however the effect of J-PKAca on inflammation in the liver microenvironment is not known. Here we report a new zebrafish model of FLC with non-invasive live imaging capabilities that allows the study of the interactions between immune cells and transformed hepatocytes. We found that overexpression of the dnajb1a-prkcaaa fusion gene specifically in hepatocytes induces early malignancy features in FLC transgenic larvae, such as increased liver and hepatocyte size. In addition, this aberrant form of PKA promotes a proinflammatory liver microenvironment by increasing the number of neutrophils and macrophages in the liver area and inducing macrophage polarization to a pro-inflammatory phenotype. Increased caspase-a activity was also found in the liver of FLC transgenic larvae. Importantly, pharmacological inhibition of TNFα secretion and caspase-a activity decreased liver size and inflammation. Overall, these findings suggest that inflammation may be an early feature of FLC involved in progression, and that targeting TNFαand caspase-1 may be beneficial in treating FLC.
Introduction:
Fibrolamellar Hepatocellular Carcinoma (FLC) is a rare and understudied liver cancer that primarily affects adolescents and young adults. Surgery (resection/liver transplantation) is the most common treatment with the best prognosis for FLC patients; however, recurrence is very common in FLC patients. Unfortunately, few therapeutic strategies are available, and they are not very effective.
Most studies have focused on identifying molecular targets that drive the disease and specific FLC tumor markers (Dhingra et al., 2010; Graham et al., 2015; Honeyman et al., 2014; Li et al., 2010; Oikawa et al., 2015; Ross et al., 2011; Simon et al., 2015) . There is only one identified molecular target responsible for driving the disease, resulting from a 400kb deletion on chromosome 19, the DNAJB1-PRKACA fusion transcript (Honeyman et al., 2014; Simon et al., 2015) . Recently developed murine models using CRISPR/Cas9 or overexpression of this fusion gene support the idea that the fused DNAJB1-PRKACA gene alone is sufficient to drive tumorigenesis in vivo (Engelholm et al., 2017; Kastenhuber et al., 2017) .
The biochemical features of the chimeric protein encoded by DNAJB1-PRKACA are a major research focus in the field (Graham et al., 2018; Riggle et al., 2016) . The DNAJB1-PRKACA transcript comprises the J-domain of DnaJB1 (the amino-terminal 69 residues) fused to the carboxyl-terminal 336 residues of the PKAcα. Importantly, the chimeric protein, J-PKAcα, is enzymatically active (Simon et al., 2015; Xu et al., 2015) . However, it is still unclear how the physiological properties of this aberrant PKA cause FLC. PKA is a key regulator of both the innate and adaptive immune response (Serezani et al., 2008; Skalhegg et al., 2005) . Innate immune cells play a role in liver cancer development and progression (de Oliveira et al., 2019; Kuang et al., 2009; Kuang et al., 2011; Li et al., 2015; Yan et al., 2015; Yan et al., 2017) , but the effect of J-PKAcα on immune cells and subsequent modulation of the liver microenvironment and FLC progression is still unclear. There is a need for animal models amenable to studying immune celltumor cell interactions with non-invasive live imaging. Therefore, to study immune cell-cancer cell 4 interactions in an intact animal in vivo we developed a FLC zebrafish model. Zebrafish have unmatched live imaging capabilities and scalability, and they are amenable to whole-organismlevel experiments and genetic and pharmacological manipulations. Hepatocyte-specific overexpression of the dnajb1a-prkcaa fusion transcript promotes early malignancy features in zebrafish FLC larvae and formation of masses in adults. In addition, expression of J-PKAcα in hepatocytes induces infiltration of neutrophils and macrophages into the liver area and macrophage polarization to a pro-inflammatory phenotype in 7 days-post-fertilization FLC transgenic larvae. Caspase-a activity in the liver is also increased. Finally, using a pharmacological approach to target inflammation and FLC progression, we found that inhibition of TNFα or caspase-a decreased neutrophil and macrophage infiltration and liver size in FLC larvae.
Overall, our data suggest that inflammation occurs early in FLC larvae and that pharmacological inhibition of TNFα secretion and caspase-a activity might be targets to treat inflammation and progression in FLC. 6 yielded no difference in collagen deposition between FLC livers and controls (data not shown). Our findings suggest that dnajb1a-prkacaa overexpression specifically in hepatocytes can induce features associated with tumorigenesis in vivo in zebrafish.
FLC transgenic larvae display early malignancy features. Zebrafish larvae are a valuable model to study the early cellular and molecular events involved in liver cancer progression (de Oliveira et al., 2019; Huang et al., 2017; Nguyen et al., 2012; Yan et al., 2015; Yan et al., 2017; Zhao et al., 2016) . Next, we wanted to determine if FLC transgenic larvae displayed early malignancy features. Liver size is a common measurement used to quantify liver disease progression (de Oliveira et al., 2019; Evason et al., 2015; Yan et al., 2015) . Liver area and liver volume were increased in 7 days post-fertilization (dpf) FLC larvae compared to control siblings ( Fig. 3A -C; Suppl. Movie S1 and S2). We next took advantage of the optical accessibility of zebrafish larvae to evaluate the size of hepatocytes in vivo by non-invasive live imaging. We outcrossed the FLC transgenic line, Tg(fabp10a:dnajb1a-prkacaa_cryaa:Cerullean), with a line that expresses Kras in the hepatocyte membrane, Tg(fabp10a:mCherry-Kras) ( Table 1 ). In FLC larvae, we observed an increase of hepatocytes area and diameter ( Fig.3 D-F). Altogether, these data suggest that ectopic expression of dnajb1a-prkacaa fusion in hepatocytes induces hepatomegaly and that 7dpf FLC larvae can be used to study early FLC progression.
Aberrant PKA induces innate immune cell infiltration in the liver area.
Increased infiltration of neutrophils and macrophages has been associated with liver cancer progression (de Oliveira et al., 2019; Yan et al., 2015) . It is still unclear how J-PKAca affects the immune cell composition in the liver microenvironment. We next outcrossed the FLC transgenic fish with labeled hepatocytes, Tg(fabp10a:dnajb1a-prkacaa_cryaa:Cerullean)/(fabp10a:EGFP-l10), with the double transgenic neutrophil and macrophage labeled line, Tg(mpeg1-mCherrycaax/lyzc:bfp) (Table 1) ( Fig. 4A ). We found that overexpression of the aberrant PKA increases both neutrophil and macrophage infiltration to the liver area in FLC transgenic larvae compared to control siblings ( Fig. 4A-C) . Time lapse-movies of the liver microenvironment area (Suppl. Movie S2) revealed robust recruitment of neutrophils to livers of FLC transgenic larvae compared to control siblings at this early phase. Livers of FLC larvae also exhibited an increased presence of macrophages in association with transformed hepatocytes that exhibited a round shape (Suppl.
Movie S3 and S4). Overall, these data suggest that the presence of J-PKAca triggers an inflammatory response in the liver of FLC larvae.
FLC transgenic larvae have increased pro-inflammatory macrophages and Caspase-a
activity in the liver. In our previous work, we found that the presence of pro-inflammatory macrophages in the liver microenvironment at early stages of progression in HCC larvae is associated with increased tumorigenesis in a model of non-alcoholic fatty liver disease-associated HCC (NAFLD-associated HCC) (de Oliveira et al., 2019) . Nothing is known about the effect of J-PKAca on macrophage polarization in vivo. To identify pro-inflammatory macrophages, we outcrossed the FLC transgenic line, Tg(fabp10a:dnajb1a-prkacaa_cryaa:Cerullean), with a reporter line of TNFα expression, Tg(tnfa:egfp) (Table 1) . TNFα is a main molecular player in liver disease progression (Jang et al., 2014) and is mostly expressed by resident macrophages in the liver (Nakashima et al., 2013; Tosello-Trampont et al., 2012) . We found that FLC transgenic larvae have increased numbers of TNFα-positive macrophages compared to control siblings ( Fig. 4A-B ). In a recent study with a FLC murine model, a ssGSEA analysis for select functionally annotated gene sets showed an upregulation of genes associated with the inflammasome complex ((Kastenhuber et al., 2017) . We therefore sought to determine if dnajb1a-prkacaa fusion transcript induces inflammasome activation via the activation of caspase-a, the zebrafish homologue for human caspase-1 (Angosto et al., 2012; Tyrkalska et al., 2016) . Using FAM-FLICA assay, we found that caspase-a activity is significantly increased in the liver of FLC transgenic larvae compared to controls ( Fig. 4C-D) . Overall, our data suggest that J-PKAca promotes a pro-inflammatory liver microenvironment at early stages of FLC progression.
Pharmacological inhibition of TNF-alpha secretion and caspase-a activity decreases
inflammation and FLC progression. Zebrafish larvae are a powerful tool for small molecule screening in disease models (Wiley et al., 2017) . Current therapeutic options for FLC patients are limited. Therefore, we decided to use a pharmacological approach to target inflammation and address its effect on FLC early progression. Our findings demonstrated an increase of proinflammatory macrophages (TNF-alpha positive) and caspase-a activity in the liver of FLC larvae ( Fig. 4) . Therefore, we next tested if inhibition of TNF-alpha secretion and caspase-a with pentoxifylline (PTX) and Ac-YVAD-CMK (C1INH), respectively, affected innate immune cell infiltration and liver size in FLC transgenic larvae. We observed that both treatments significantly decreased liver size as well as macrophage and neutrophil recruitment to the liver of FLC transgenic larvae ( Fig. 5A-D) . We also tested the effects of metformin on FLC. We and others have shown that metformin decreases inflammation and associated liver disease progression (de Oliveira et al., 2019; Li et al., 2019; Satapati et al., 2015) . Surprisingly, we found that metformin treatment of FLC larvae did not affect liver size or macrophage infiltration ( Fig. 5A-C ). However, a small decrease in neutrophil infiltration was observed in FLC larvae treated with metformin ( Fig. 5 A and D). Overall, our data suggest that TNF-alpha secretion and caspase-a activity mediate FLCassociated liver inflammation and may represent a new target to limit FLC progression.
Discussion
Fibrolamellar Hepatocellular Carcinoma (FLC) is a rare pediatric liver cancer with few effective therapeutic options. The fusion chimera DNAJB1-PRKACA (J-PKAcα) has been identified as a unique driver of FLC (Graham et al., 2015; Honeyman et al., 2014; Simon et al., 2015) . Here we report a zebrafish model for FLC generated by hepatocyte-specific ectopic expression of the zebrafish form of DNAJB1-PRKACA, dnajab1a-prkacaa. We find that the dnajab1a-prkacaa fusion transcript induces early hepatomegaly and inflammation in the liver area. One striking feature is that onset of inflammation is early and is characterized by the presence of TNFa positive macrophages, a feature that is not present in the standard catenin model of HCC (de Oliveira et al., 2019) . In addition, this model provides a powerful tool to identify small molecules that alter inflammation and liver enlargement induced by dnajab1a-prkacaa.
Our findings show that the J-PKAcα fusion is sufficient to induce early stages of tumorigenesis, including liver enlargement and inflammation. However, there was a low incidence of mass formation in adult fish observed with dnajab1a-prkacaa. FLC transgenic fish develop masses, suggesting that, as in murine models, overexpression of dnajab1a-prkacaa is sufficient to drive tumorigenesis in vivo. However, FLC incidence was surprisingly low (1/8 at 8-months of age and 1/7 at 12-months). This may be due to low expression level or use of only one homologue of the DNAJB1 and PRKACA genes, the alpha form, dnajab1a-prkacaa, due to its higher identity and similarity with the human DNAJB1-PRKACA. However, the beta form dnajb1b-prkacab may have an important role in the liver acting in parallel with the alpha form and therefore affecting different pathways. In the future, it would be interesting to investigate whether the incidence of FLC tumorigenesis in zebrafish is increased by overexpression of dnajb1b-prkacab alone or combined with dnajab1a-prkacaa. In addition, as in the murine model, the masses found in FLC transgenic zebrafish lack markers of fibrosis seen in human FLC. This feature might be a crucial step for the progression of the disease and might be achieved with the use of fibrotic simulants (Kastenhuber 1 0 et al., 2017) . It is also possible that the activation of additional signaling pathways such as WNT/βcatenin (Kastenhuber et al., 2017) might be used to enhance dnajb1a-prkacaa tumorigenesis in vivo in zebrafish.
The function and activity of J-PKAcα has been another major focus of study in the field since drugs that target PKA activity could be a potential therapeutic option for FLC patients. Up to now, most data suggest that J-PKAcα fusion is enzymatically active and necessary for tumorigenesis in vivo (Kastenhuber et al., 2017) . PKA activity mostly exerts an anti-inflammatory role (Campo et al., 2012) and is a major regulator of innate immune cells (Serezani et al., 2008) . Several clinical drugs that target cAMP/PKA signaling pathway increase cAMP and are used to reduce inflammation and treat inflammatory disorders (Banner and Trevethick, 2004; Serezani et al., 2008) . Importantly, immune cells are a main source of trophic support for transformed cancer cells and can play a role in the early progression of cancer (Feng et al., 2010; Giese et al., 2019; Powell and Huttenlocher, 2016) including liver cancer (Yan et al., 2015; Yan et al., 2017; Zhao et al., 2016) . The role of J-PKAcα on the innate immune system is completely unclear. Using fluorescent labeled transgenic zebrafish larvae as a model, we and others are able to visualize the early interactions between immune cells and transformed hepatocytes and study the immune mechanisms involved in liver disease and cancer progression through non-invasive live imaging (de Oliveira et al., 2019; Yan et al., 2015; Yan et al., 2017) . In theory, we would predict that the chimeric protein J-PKAcα would inhibit the innate immune response. Surprisingly, we observed the opposite-increased innate immune inflammation in our FLC transgenic model with increased neutrophil and macrophage infiltration into the liver, as well as.an increase of TNFα-positive macrophages. These data suggest that the J-PKAcα fusion protein promotes a pro-inflammatory liver microenvironment. The Recurrence after complete surgical resection is common in FLC patients (Kassahun, 2016) . The therapeutic strategies available for these patients with FLC relapse are limited and often not effective. Therefore, the discovery of new and improved therapeutic targets is a primary goal in this field. FLC zebrafish larvae models could be a powerful tool to aid in the identification of new drug targets using small molecule screening. Importantly, zebrafish larvae models display similar features of liver cancer progression (Goessling and Sadler, 2015; Huo et al., 2019; Lam et al., 2006; Li et al., 2014; Li et al., 2013; Wrighton et al., 2019; Zheng et al., 2013) . Here we used a pharmacological approach to inhibit TNFα secretion and caspase-a activity in FLC larvae, since both TNFα and caspase activity were increased. We found that inhibition of both TNFα secretion and caspase-a activity both reduced innate immune cell infiltration in the liver as well as liver size, an established marker for liver disease progression (de Oliveira et al., 2019; Evason et al., 2015;  1 2 Lam et al., 2006; Nguyen et al., 2012; Zheng et al., 2014) . These findings support the potential of these approaches to reduce inflammation and decrease FLC progression. Further studies, with other FLC in vitro and in vivo models are needed to confirm the potential of these drugs to reduce FLC progression or recurrence.
Here we report a new FLC zebrafish model with unmatched non-invasive live imaging capabilities and scalability amenable to high-throughput drug screening. Overall, our findings support the idea that non-resolving inflammation might be fueling the liver microenvironment and contributing to FLC pathology. In addition, we found that pharmacological inhibition of TNFα secretion and caspase-a activity might be targets to treat inflammation and progression in FLC. In the future, it will be interesting to address how the FLC pro-inflammatory liver environment modulates the adaptive immune system; zebrafish models might be key tools in unraveling such mechanisms and finding new and improved therapeutic targets for FLC.
3

Materials and Methods:
Zebrafish husbandry and maintenance
All protocols using zebrafish in this study were approved by the University of Wisconsin-Madison Institutional Animal Care and Use Committee. Adult zebrafish and embryos up to 5 days postfertilization (dpf) were maintained as described previously (de Oliveira et al., 2019) . At 5 dpf, larvae were transferred to 15cm petri dishes and kept in E3 media without methylene blue until 7dpf. For all experiments, larvae were anesthetized in E3 media without methylene blue containing 0.16 mg/ml Tricaine (MS222/ethyl 3-aminobenzoate; Sigma-Aldrich). Zebrafish lines used are summarized in Table 1 .
Generation of Tg(fabp10a:dnajb1a-prkacaa_cryaa:Cerulean), Tg(fabp10a:egfp-l10a) and Tg(fabp10a:mcherry-Kras) lines
For Tg(fabp10a:dnajb1a-prkacaa_cryaa:Cerulean) , DNA coding sequence for dnajb1a-prkacaa fusion gene was PCR amplified from a plasmid synthetized by IDT using following primers: 
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For Tg(fabp10a:egfp-l10a) DNA coding egfp-l10a was PCR amplified from a plasmid (Davenport et al., 2016) , using following primers:
Resulting PCR products were gel purified and cloned using InFusion kit (Clontech) into an expression vector containing fabp10a promoter sequence, minimal Tol2 elements for efficient integration and an SV40 polyadenylation sequence, previously digested with KpnI and XbaI and gel purified. Casper fish were injected and screened for EGFP expression in the liver as described above.
For Tg(fabp10a:mCherry-Kras) DNA coding Kras was PCR amplified from a plasmid (Freisinger and Huttenlocher, 2014), using following primers:
Fw: 5'-ACGAGCTGTACAAGTCCGGAATGACTGAATATAAACTTGTGGTGGTG -3' Rv: 5'-CTGATTATGATCTAGATTACATAATTACACACTTTGTCTTTGACTTCT -3'
Resulting PCR products were gel purified and cloned using InFusion kit (Clontech) into an expression vector containing fabp10a promoter sequence, mCherry sequence, minimal Tol2 elements for efficient integration and an SV40 polyadenylation sequence, previously digested with BspEI and XbaI and gel purified. Casper fish were injected and screened for mCherry expression in the liver as described above.
Liver dissection and Histology
Adult zebrafish (8 and 12 months of age) were euthanized by tricaine overdose and the livers removed by dissection. Livers were fixed in 10% formalin overnight. Samples were coded to facilitate blinded histopathologic evaluation. The livers were paraffin-embedded and 4um sections 1 5
were prepared and stained with hematoxylin and eosin. Slides were evaluated by a board-certified veterinary pathologist (RH).
Live imaging
All live imaging was performed using a zWEDGI device as previously described (Huemer et al., 2017) . For time-lapse imaging, the loading chamber was filled with 1% low melting point agarose (Sigma) in E3 to retain the larvae in the proper position. Additional Tricaine/E3 was added as needed. All images were acquired with live larvae with the exception of FLICA staining. Images were acquired on a spinning disk confocal microscope (CSU-X; Yokogawa) with a confocal scanhead on a Zeiss Observer Z.1 inverted microscope equipped with a Photometrics Evolve EMCCD camera using a Plan-Apochromat 20x/0.8 M27 air objective with a 5μm interval. For larvae with large livers, 2x2 tile images were taken.
Liver and hepatocytes size measurements.
For liver size measurements, 7dpf Tg(fabp10a:dnajb1a-prkacaa_cryaa:Cerulean) were outcrossed with Tg(fabp10a:egfp-l10a). For hepatocyte measurements, Tg(fabp10a:dnajb1a-prkacaa_cryaa:Cerulean) were outcrossed with Tg(fabp10a:mCherry-Kras). Liver area, liver volume, hepatocyte area and hepatocyte diameter were measured as previously described (de Oliveira et al., 2019) .
Quantification of neutrophil and macrophage recruitment
To quantify leukocyte recruitment we outcrossed double transgenic FLC line carrying the EGFP- (Miskolci et al., 2019) . After live imaging, Z series images were 3D reconstructed on Imaris software. Using the Imaris spots tool, total macrophages (mpeg1:mCherry-caax positive cells) were counted within 50μm from liver. TNFα positive macrophages (double positive mpeg1:mcherry/Tnfα:egfp cells) were quantified similarly. Z series images were reconstructed on Zen software to create maximum intensity projections.
Drug treatment
Larvae were treated with metformin (MET), pentoxifylline (PTX) and Ac-YVAD-CMK (C1INH) as described previously (de Oliveira et al., 2019) (REF Sylwia paper) . Briefly, we dissolved metformin (Enzo Life Sciences) in E3 without methylene blue at a final concentration of 50 µM. Pentoxifyline and AC-YVAD-CMK were first reconstituted in DMSO and later diluted 1000x in E3 without methylene blue at final concentration of 50 µM and 100 µM, respectively. Larvae were treated with these drugs from 3 to 7dpf. Drugs were freshly prepared and replaced daily.
Caspase-1 activity assay
Larvae with 6dpf were incubated with FAM-FLICA (Immunochemistry Technologies) at 1:300 for 12h. Next day, larvae were washed with E3 and fixed in PIPES/1.5%Formaldehyde buffer at 4C. overnight. Larvae were washed 3 times with PBS 1x and livers were carefully dissected with the use of forceps on a stereomicroscope (Leica MZ 9.5). After dissection, livers were immersed in PBS and images were acquired on a spinning disk confocal microscope (CSU-X; Yokogawa) with 1 7 a confocal scanhead on a Zeiss Observer Z.1 inverted microscope equipped with a Photometrics Evolve EMCCD camera using a EC Plan-Neofluor 40x/0.75 M27 air objective with a 1μm interval.
Mean Intensity fluorescence was measured on maximum intensity projections using Image J.
Statistical analysis
All data plotted comprise at least three independent experimental replicates. Estimated Marginal Means (EMMs) analysis in R (www.r-project.org) (Vincent et al., 2016) was performed on pooled replicate experiments, using Tukey method when comparing more than two treatments. Graphical representations were done in GraphPad Prism version 6.
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